Erythrodermic Psoriasis with Superimposed Fungal Infection-a Presentation in the Emergency Room
Erythrodermic psoriasis or erythroderma is a life-threatening, generalized exfoliative dermatitis involving majority of the body surface. A detailed evaluation is required for the identification of its underlying cause to successfully treat and prevent its relapse. We present a case of erythroderma...
| Published in: | Eurasian Journal of Emergency Medicine |
|---|---|
| Main Authors: | Muhammad Akbar Baig, Sadaf Sheikh |
| Format: | Article |
| Language: | English |
| Published: |
Emergency Medicine Physicians’ Association of Turkey
2018-03-01
|
| Subjects: | |
| Online Access: |
http://akademikaciltip.com/archives/archive-detail/article-preview/erythrodermic-psoriasis-with-superimposed-fungal-n/21753
|
Similar Items
Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022-08-01)
by: Abdulmajeed Alajlan, et al.
Published: (2022-08-01)
Heart failure in erythrodermic psoriasis: a retrospective study of 225 patients
by: Chao Wu, et al.
Published: (2023-08-01)
by: Chao Wu, et al.
Published: (2023-08-01)
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series
by: Andrea D'Arino, et al.
Published: (2025-07-01)
by: Andrea D'Arino, et al.
Published: (2025-07-01)
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
by: Megna M, et al.
Published: (2023-12-01)
by: Megna M, et al.
Published: (2023-12-01)
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]
by: Megna M, et al.
Published: (2024-06-01)
by: Megna M, et al.
Published: (2024-06-01)
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
by: Potestio L, et al.
Published: (2023-08-01)
by: Potestio L, et al.
Published: (2023-08-01)
Adalimumab-Induced Erythrodermic Psoriasis Associated with Alopecia in a Patient with Palmoplantar Pustulosis
by: Ying Wang, et al.
Published: (2024-04-01)
by: Ying Wang, et al.
Published: (2024-04-01)
Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report
by: Chen W, et al.
Published: (2022-09-01)
by: Chen W, et al.
Published: (2022-09-01)
HLA-DR Helps to Differentiate Erythrodermic Cutaneous T-cell Lymphoma from Erythrodermic Inflammatory Dermatoses in Flow Cytometry
by: Jingru Sun, et al.
Published: (2023-08-01)
by: Jingru Sun, et al.
Published: (2023-08-01)
A nomogram diagnostic cardiovascular disease in patients with erythrodermic psoriasis in Chinese
by: Yue-Min Zou, et al.
Published: (2023-06-01)
by: Yue-Min Zou, et al.
Published: (2023-06-01)
Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
by: Lu X, et al.
Published: (2023-07-01)
by: Lu X, et al.
Published: (2023-07-01)
Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
by: Song B, et al.
Published: (2024-08-01)
by: Song B, et al.
Published: (2024-08-01)
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma
by: Camille Luherne, et al.
Published: (2022-09-01)
by: Camille Luherne, et al.
Published: (2022-09-01)
Efficacy and Safety of Adalimumab and Secukinumab in Erythrodermic Psoriasis: A Single Centre Retrospective Study
by: Yachen Wang, et al.
Published: (2025-07-01)
by: Yachen Wang, et al.
Published: (2025-07-01)
Biologic anti-IL17 drugs in erythrodermic psoriasisCapsule Summary
by: Alessandro Falco, MD, et al.
Published: (2024-09-01)
by: Alessandro Falco, MD, et al.
Published: (2024-09-01)
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013-09-01)
by: Rosita Saraceno, et al.
Published: (2013-09-01)
Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic Psoriasis
by: Huijuan Shi, et al.
Published: (2024-05-01)
by: Huijuan Shi, et al.
Published: (2024-05-01)
Cutaneous T-cell lymphoma: Differential diagnostics of erythrodermic conditions
by: A. E. Karamova, et al.
Published: (2019-12-01)
by: A. E. Karamova, et al.
Published: (2019-12-01)
Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)
Efficacy and safety of biologics in erythrodermic psoriasis: a systematic review and single-arm meta-analysis
by: Lingjie Gao, et al.
Published: (2025-10-01)
by: Lingjie Gao, et al.
Published: (2025-10-01)
Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practice
by: Clara Plana, et al.
Published: (2024-06-01)
by: Clara Plana, et al.
Published: (2024-06-01)
Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
by: Lamya Noure, et al.
Published: (2021-02-01)
by: Lamya Noure, et al.
Published: (2021-02-01)
Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study
by: An-ran Ma, et al.
Published: (2021-12-01)
by: An-ran Ma, et al.
Published: (2021-12-01)
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
by: Aya Fadel, et al.
Published: (2025-06-01)
by: Aya Fadel, et al.
Published: (2025-06-01)
Efficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study
by: Yukari Okubo, et al.
Published: (2025-08-01)
by: Yukari Okubo, et al.
Published: (2025-08-01)
Update on Erythrodermic Psoriasis: Proposal of a Management Algorithm by an Innovative Severity Evaluation Approach
by: Xu JM, et al.
Published: (2025-07-01)
by: Xu JM, et al.
Published: (2025-07-01)
Topical Glucocorticoid-Induced Cushing’s Syndrome in a Patient with Erythrodermic Psoriasis: A Case Report
by: Peng X, et al.
Published: (2025-09-01)
by: Peng X, et al.
Published: (2025-09-01)
Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report
by: Qiuyu Jia, MD, PhD, et al.
Published: (2025-10-01)
by: Qiuyu Jia, MD, PhD, et al.
Published: (2025-10-01)
Efficacy of Secukinumab in Management of Erythrodermic Psoriasis: A Study in Treatment-naïve Cases
by: Aradhana Rout, et al.
Published: (2025-07-01)
by: Aradhana Rout, et al.
Published: (2025-07-01)
Successful Treatment with Secukinumab in an Erythrodermic Psoriasis Patient with End-Stage Kidney Disease on Hemodialysis: A Case Report
by: Zhang S, et al.
Published: (2025-10-01)
by: Zhang S, et al.
Published: (2025-10-01)
Dupilumab‐Induced Erythrodermic Psoriasiform Dermatitis in Chronic Actinic Dermatitis: Case Report and Innovative Treatment Approach
by: Joe Khodeir, et al.
Published: (2024-11-01)
by: Joe Khodeir, et al.
Published: (2024-11-01)
Effectiveness, quality of life, and safety of secukinumab versus conventional systemic therapy in patients with erythrodermic psoriasis: a comparative study
by: Ying Zhou, et al.
Published: (2024-11-01)
by: Ying Zhou, et al.
Published: (2024-11-01)
Comparison of inflammation-related clinical characteristics and laboratory parameters among different types of psoriasis
by: Zengqi TANG, et al.
Published: (2022-10-01)
by: Zengqi TANG, et al.
Published: (2022-10-01)
Safe and effective management of psoriasis through Ayurveda: A case report
by: Guruprasad C. Nille, et al.
Published: (2025-03-01)
by: Guruprasad C. Nille, et al.
Published: (2025-03-01)
Erythrodermic Manifestation due to Hyperinfestation of Scabies
by: Sandra Widaty, et al.
Published: (2021-07-01)
by: Sandra Widaty, et al.
Published: (2021-07-01)
Efficacy of Bimekizumab in the Management of Refractory Erythrodermic Pityriasis Rubra Pilaris: Clinical Insights
by: Sofia Theotokoglou, et al.
Published: (2025-07-01)
by: Sofia Theotokoglou, et al.
Published: (2025-07-01)
Erythrodermic cutaneous T-cell lymphoma: Insights from a Kenyan perspective
by: Caroline Mutio, MBChB, et al.
Published: (2025-10-01)
by: Caroline Mutio, MBChB, et al.
Published: (2025-10-01)
Erythrodermic Mycosis Fungoides: The Algorithm of Diagnosis and Treatment
by: OYu Olisova, et al.
Published: (2018-10-01)
by: OYu Olisova, et al.
Published: (2018-10-01)
Adapting the Goeckerman Regimen for Psoriasis Treatment in Kenya: A Case Study of Successful Management in a Resource-Limited Setting
by: Smith P, et al.
Published: (2024-08-01)
by: Smith P, et al.
Published: (2024-08-01)
Erythrodermic scabies in an immunocompetent patient
by: Ronan Talty, BS, et al.
Published: (2022-11-01)
by: Ronan Talty, BS, et al.
Published: (2022-11-01)
Similar Items
-
Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022-08-01) -
Heart failure in erythrodermic psoriasis: a retrospective study of 225 patients
by: Chao Wu, et al.
Published: (2023-08-01) -
Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series
by: Andrea D'Arino, et al.
Published: (2025-07-01) -
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
by: Megna M, et al.
Published: (2023-12-01) -
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]
by: Megna M, et al.
Published: (2024-06-01)
